Skip to main content

Table 1 Basic demographic and clinical characteristics and coagulation factors of patients before PEX therapy

From: Effects of preoperative plasma exchange therapy with albumin replacement fluid on blood coagulation in patients undergoing ABO-incompatible living-donor kidney transplantation using rotational thromboelastometry

 

PEX (+)

PEX (−)

P value

Number of patients

13

15

 

Age (year)

42.2 ± 13.9

45.9 ± 14.9

0.496

Weight (kg)

59.4 ± 12.5

66.0 ± 15.7

0.239

Body mass indexa

22.5 ± 4.0

23.5 ± 5.3

0.550

Anesthesia time (min)

415 ± 69.5

400 ± 87.2

0.601

Surgical time (min)

307 ± 55.9

299 ± 88.0

0.763

Male/female

6/7

10/5

0.445

Dialysis (%)a

53

40

0.705

Hypertension (%)a

92

87

1.000

Diabetic mellitus (%)a

23

40

0.435

Platelet (× 103/μl)

205.2 ± 61.3

233.8 ± 57.2

0.213

Fibrinogen (mg/dl)

322.8 ± 87.4

299.8 ± 65.8

0.496

Hemoglobin (g/dl)

11.7 ± 1.6

11.7 ± 1.6

0.995

Hematocrit (%)

35.1 ± 5.3

36.0 ± 4.8

0.647

  1. Data are presented as the ratio (%) and mean ± standard deviation. The two groups were compared using an unpaired t-test, unpaired t-test with Welch’s correction or aFisher’s exact test
  2. Abbreviations: % dialysis percentage of dialysis, BMI body mass index (weight (kg) / height squared (m2))
Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us